DRAPER, Utah, Nov. 25, 2013 /PRNewswire/ -- Nutranomics, Inc. (OTCBB: NNRX) (OTCQB: NNRX) ("Nutranomics" or the "Company") is pleased to announce that the Company has completed a Licence Agreement with Genesar Nutraceuticals, LLC ("Genesar") to acquire the worldwide exclusive marketing and distributing rights to GenEpic™, a natural therapeutic treatment formula currently the subject of an IRB reviewed (FDA regulated) phase II human clinical study on prostate cancer treatment and recovery. Under the terms of the Licence Agreement, Nutranomics will hold the worldwide licence for GenEpic™ including all intellectual property relating to it and any associated trade secrets for a period of thirty (30) years in exchange for the following: i) 100,000 restricted shares of NNRX common stock; ii) a royalty fee of $4.00/box of GenEpic™ sold by Nutranomics; and iii) payment of $200,000 as advance royalties on the first 4,000 boxes sold, due in December 2013. "We are extremely pleased to have finalized an agreement for the worldwide rights to GenEpic™ in advance of the completion of its current phase II human clinical study," stated Dr. Tracy K. Gibbs, Nutranomics CEO. "Following the successful completion of the study, we will be well-positioned to market and distribute GenEpic globally while leveraging the strength of an IRB reviewed human clinical study." GenEpic™ is a natural therapeutic formula containing 70 vitamins and minerals, 32 herbs, and 16 enzymes and phytonutrients, and formulated by a respected team of five scientists and natural medicine experts, including Dr. Gibbs. GenEpic™ is currently the subject of an IRB reviewed (FDA regulated) phase II human clinical study on prostate cancer treatment and recovery being conducted at OH Research Group in Salt Lake City, Utah. The Company expects the GenEpic™ phase II human clinical study to be completed within the next 60 days. Dr. Gibbs concluded, "It's very rare that a nutraceutical product like GenEpic™ is subjected to this kind of strict human clinical study. I look forward to using this fact to our advantage as we build awareness for the product globally among consumers and potential distributors." About Nutranomics Nutranomics is a publicly traded company engaged in research and development of nutritional food products. In 1997, Nutranomics produced and branded its own product line, and began to sell to the retail outlets and to the public. Nutranomics has also produced formulas for hundreds of other companies. Nutranomics' mission is to increase human health and longevity through education and self-awareness. The Company has sales representatives throughout North America and Asia. For further information regarding Nutranomics, Inc., please contact our investor relations representatives at ir@nutranomics.com or call toll-free (888) 616-3999. Notice Regarding Forward-Looking Statements This news release contains "forward-looking statements." Statements in this press release that are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, but are not limited to, the outcome of the GenEpic human clinical study and the implied potential for revenue and/or profits from GenEpic sales. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with developing new products and operating as a development stage company, our ability to raise the additional funding we will need to continue to pursue our business and product development plans, competition in the industry in which we operate and market conditions. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements, except as required by applicable law, including the securities laws of the United States. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in the reports and other documents we file with the SEC, available at www.sec.gov. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease. SOURCE Nutranomics, Inc. Copyright 2013 PR Newswire
Category: CryptoTotal Views: 23 By : EditorUpdated: 05-18-2024
Crypto Market Cycles Identifying Bull and Bear Phases
Market cycles can sometimes be hard to understand, even for people who have been investing for a long time. Fear not though because if you can predict how the crypto market will move then it is possible for you to make money from your investment.
Now we are going to explain the psychology of these cycles. We will give you tips on how to survive in this world of cryptos that keeps on changing its shape.
We do not stop until we have sh... Continue Reading
Category: StocksTotal Views: 62 By : EditorUpdated: 05-17-2024
Introduction
As we end another trading day on Wall Street What I Did After My High School Graduation, it is important to analyze how the market performed on May 17th, 2024. The Dow Jones Industrial Average (DJIA) reached a new all-time high which acted as one of the key highlights of the day. This took place against mixed movements in global markets and a ton of economic data releases that kept investors busy. Here is more information.
Market Performance
Dow Jones Industrial Average (DJ... Continue Reading
Category: BusinessTotal Views: 256 By : EditorUpdated: 05-16-2024
Crafting a business-winning strategy is like determining the direction of your business in the modern business world, which is currently so accustomed to turmoil and uncertainty caused by the rapidly changing market, and then what follows, the surviving squabbles of competition, adaptation to the consumers' needs ceaselessly changing. What will lead you to sustainability and help you create a unique competitive advantage through which you can stand out? It is up to the business strategy for ... Continue Reading
Category: StocksTotal Views: 240 By : EditorUpdated: 05-16-2024
Mastering Stock Market Investing: Unlock the Secrets of Stock Price Analysis
Ever thought of how some investors easily move around the dire world of stock market investing, bringing with them insightful decisions contributing a lot to their investment returns? Think of a situation where you are able to predict the moves of stock prices, unlock the secrets that move successful trading operations.
To overcome the myriad of scenarios in the investment world, becoming a stock market investing ... Continue Reading
Category: MarketsTotal Views: 255 By : EditorUpdated: 05-16-2024
Introduction to Stock Futures
A stock future is a kind of financial agreement that obligates the purchaser to buy, and the dealer to sell, a certain quantity of shares at a preset price on a specified future day. This sector of the finance market is very important for many players such as investors, daily traders, and financial analysts. Learning about stock futures can bring about significant benefits in managing risks, speculating and planning investment strategies.
How Stock Futures Wor... Continue Reading
Category: MarketsTotal Views: 237 By : EditorUpdated: 05-16-2024
Summary
The stock market showed a fluctuating performance today with main indexes reaching new tops before falling slightly at the day's end. The Dow Jones Industrial Average (DJIA) attention as it momentarily went past the 40,000 points mark, a historic high, but ended at 39,869 points. Here is a look at the happenings of the day and what they mean.
Market Review, Index Progress and Economic Figures
Index Performance:
Dow Jones Industrial Average (DJIA): Despite reaching an a... Continue Reading
Category: StocksTotal Views: 297 By : EditorUpdated: 05-16-2024
Another Trading Day is Underway
May 16: 2024: the stock market has been showing cautious optimism as several indices hit or nearly hit record highs.
The following is an overview of the present:
Indices Performances:
Dow Jones Industrial Average (I:DJI) Dow Jones holds steady with no daily change: standing at $39.91k. Its trading volume stands high at 411.19 million.
S&.P 500 (I:SPX): It also shows no daily change: with a value of $5.31k and an extensive trading volume of 4.3... Continue Reading
Category: StocksTotal Views: 336 By : EditorUpdated: 05-16-2024
A Dive into Penny Stocks vs. Regular Stocks: Understanding the Contrasts
Have you ever received to the question "penny stocks or regular stocks - which type of stocks can bring me a sky-high investment portfolio?" Picture this: you're at the heart of stock market maize in search of the road that will get you to the milestones in your financial life as well. Knowing the difference between penny stocks with their attraction of the volatile market and regular stocks with its stable... Continue Reading
Category: InvestingTotal Views: 360 By : EditorUpdated: 05-16-2024
How to Determine Your Risk Tolerance: A Step-by-Step Guide
Do you want to be the one who determines your financial future, but be unclear about how much risk you are to judge your investments? Having a clear understanding of your risk tolerance is a must because it's the very first step to be able to choose the right investment decision to be made out of a purpose-built set of the criteria you've listed before. Consequently, the concept of risk tolerance is to each person as diverse a... Continue Reading
Category: StocksTotal Views: 365 By : EditorUpdated: 05-16-2024
Unveiling Hidden Gems: Strategies to Identify Undervalued Penny Stocks
Did you always think about the thrill of this world, the world where undervalued penny stocks roam? Visualize yourself finding gems that have the potential to increase your investment returns by how many times the number of desktops you have in your office, leading to your masters in finance. How would you implement it? There are limitless possibilities of getting rich by picking out the diamonds before they become mass ma... Continue Reading